ST. LOUIS (KMOX) – A cheap chemotherapy drug tested in St. Louis has been found to extend life for more than a year for men whose prostate cancer has spread.
Men who received docetaxel lived nearly 58 months longer, versus 44 months for those who only received hormone therapy.
“Saint Louis University was one of the trial sites for this trial, and so we do intend to continue this treatment with patients who have metastatic disease,” says SLU Hospital urologist Dr. Sameer Saddiqui. “Instead of giving them hormones alone, we’re going to give them hormones and chemotherapy.”
Side effects include possible fever and a tingling in the fingers and toes, but Saddiqui says the extended survival rate is well worth that trade off.
(TM and © Copyright 2014 CBS Radio Inc. and its relevant subsidiaries. CBS RADIO and EYE Logo TM and Copyright 2014 CBS Broadcasting Inc. Used under license. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)
MORE HEALTH NEWS:
- Birth Control Pills May Prevent Some Cancers, Study Finds
- Tide Pod Challenge Leads To Tide Pod-Inspired Food
- Sushi Lover Pulls 5-Foot Tapeworm From His Own Body
- Blood Test to Detect 8 Cancers Early Gives Promising Results
- Hospitals Teaming Up To Start Not-For-Profit Drug Company To Combat Drugmakers’ High Prices
- Physicals Key to Finding Heart Attack Risks, Doctor Says